Skip to main content
TipRanks
Go Ultimate75% OFF

HLB Life Science Co.,Ltd. (067630) Stock Statistics & Valuation Metrics

Total Valuation

HLB Life Science Co.,Ltd. has a market cap or net worth of KRW 286.34B. The enterprise value is KRW 547.93B.

Market Cap
KRW 286.34B
Enterprise Value
KRW 547.93B

Share Statistics

HLB Life Science Co.,Ltd. has 121,917,060 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
121,917,060
Owned by Insiders
―
Owned by Institutions
5.06%

Financial Efficiency

HLB Life Science Co.,Ltd.’s return on equity (ROE) is -0.34 and return on invested capital (ROIC) is -4.51%.

Return on Equity (ROE)
-0.34
Return on Assets (ROA)
-0.21
Return on Invested Capital (ROIC)
-4.51%
Return on Capital Employed (ROCE)
-0.06
Revenue Per Employee
―
Profits Per Employee
―
Employee Count
―
Asset Turnover
0.10
Inventory Turnover
6.81

Valuation Ratios

The current PE Ratio of HLB Life Science Co.,Ltd. is -32.21. HLB Life Science Co.,Ltd.’s PEG ratio is -0.02.

PE Ratio
-32.21
PS Ratio
0.00
PB Ratio
4.61
Price to FCF
0.00
Price to Operating Cash Flow
-88.49
PEG Ratio
-0.02

Income Statement

In the last 12 months, HLB Life Science Co.,Ltd. had revenue of 45.75B and earned -99.79B in profits. Earnings per share was -818.56.

Revenue
45.75B
Gross Profit
-494.41M
Operating Income
-21.02B
Pretax Income
-100.57B
Net Income
-99.79B
EBITDA
-83.58B
Earnings Per Share (EPS)
-818.56

Cash Flow

In the last 12 months, operating cash flow was -22.93B and capital expenditures -25.94B, giving a free cash flow of -48.88B billion.

Operating Cash Flow
-22.93B
Free Cash Flow
-48.88B
Free Cash Flow per Share
-266.89

Dividends & Yields

HLB Life Science Co.,Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
―
Earnings Yield
-3.11%

Stock Price Statistics

Beta
0.52
52-Week Price Change
-48.58%
50-Day Moving Average
3198.10
200-Day Moving Average
3344.47
Relative Strength Index (RSI)
29.92
Average Volume (3m)
562.58K

Important Dates

HLB Life Science Co.,Ltd. upcoming earnings date is Mar 25, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 12, 2026
Next Earnings Date
Mar 25, 2027
Ex-Dividend Date
―

Financial Position

HLB Life Science Co.,Ltd. as a current ratio of 0.58, with Debt / Equity ratio of 53.93%

Current Ratio
0.58
Quick Ratio
0.52
Debt to Market Cap
0.11
Net Debt to EBITDA
-1.76
Interest Coverage Ratio
-1.79

Taxes

In the past 12 months, HLB Life Science Co.,Ltd. has paid -666.74M in taxes.

Income Tax
-666.74M
Effective Tax Rate
0.01

Enterprise Valuation

HLB Life Science Co.,Ltd. EV to EBITDA ratio is -1.74, with an EV/FCF ratio of -4.52.

EV to Sales
4.05
EV to EBITDA
-1.74
EV to Free Cash Flow
-4.52
EV to Operating Cash Flow
-9.49

Balance Sheet

HLB Life Science Co.,Ltd. has KRW 13.88B in cash and marketable securities with KRW 160.36B in debt, giving a net cash position of -KRW 146.48B billion.

Cash & Marketable Securities
KRW 13.88B
Total Debt
KRW 160.36B
Net Cash
-KRW 146.48B
Net Cash Per Share
-KRW 1,201.47
Tangible Book Value Per Share
KRW 2,017.83

Margins

Gross margin is -0.96%, with operating margin of -43.15%, and net profit margin of -117.47%.

Gross Margin
-0.96%
Operating Margin
-43.15%
Pretax Margin
-118.81%
Net Profit Margin
-117.47%
EBITDA Margin
-232.45%
EBIT Margin
-244.20%

Analyst Forecast

The average price target for HLB Life Science Co.,Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-42.14%
EPS Growth Forecast
52.55%

Scores

Smart Score
―
AI Score
44